Dr. Gautam Goyal is a highly accomplished Medical Oncologist and Hemato-Oncologist with advanced training from Tata Memorial Hospital, India’s premier cancer center. He is an ESMO Certified Medical Oncologist with international exposure through ASH (USA), ACORD (Australia), APBMT, and global oncology congresses. With deep expertise in solid tumors, blood cancers, and bone marrow transplants, Dr. Goyal is widely recognized for his academic excellence, clinical research, and contributions to cancer education. He has numerous high-impact publications and has served as Editor-in-Chief for the Lung Cancer Consortium Asia.
Educational Qualifications:
- Faculty (Lung Cancer Session), UAE Cancer Congress (2013)
- American Society of Hematology (ASH), Atlanta (2012)
- Association for Cooperative Operations Research and Development (ACORD), Australia (2012)
- Asia Pacific Bone Marrow Transplant (APBMT), India (2012)
- ESMO Certified Medical Oncologist (ECMO)
- Fellowship (Solid Tumor Oncology), Tata Memorial Hospital, Mumbai
- Conferences/Workshops attended
- DM (Medical Oncology), Tata Memorial Hospital, Mumbai
- MD (Internal Medicine), Chhatrapati Shahuji Maharaj Medical University (CSMMU)/King George Medical College (KGMC), Lucknow
- MBBS, Government Medical College, Patiala
Professional Experience:
- Dr. Gautam Goyal is currently working at Max Healthcare
- Consultant Coordinator, Department of Oncology, SPS Apollo Hospital, Ludhiana (2013-2014)
- Senior Resident, Tata Memorial Hospital, Mumbai (2009-2013)
Awards:
- Scholarship
- ICMR Travel Grant for resenting research work at American Society of Hematology (ASH), Atlanta (2012)
Research Papers & Publications:
- Tuberculosis Infection in Chronic Myelogenous Leukemia (CML) patients treated with Imagines, American Society of Clinical Oncology (ASCO) (2010)
- Estrogen, Progesterone and HER2 Receptor Expression in Breast Tumors and usage of HER2 Targeted Therapy in a Tertiary Care Centre in India, Indian Journal of Cancer (Oct-Dec 2011)
- Utility of Voriconazole Monitoring and factors affecting its levels in patients undergoing Hematopoietic Stem Cell Transplantation, American Society of Hematology (ASH) (2012)
- Hemorrhagic Cystitis Post Hematopoietic Stem Cell Transplantation - Risk factors and Treatment Outcomes, Asia Pacific Bone Marrow Transplant (APBMT) (2012)
- A Phase II study of Oral Metronomic Chemotherapy in Relapsed Epithelial Ovarian Cancer, American Society of Clinical Oncology (ASCO) (2013)
- Results of Autologous Transplants for children from a Tertiary Cancer Centre in India American Society of Clinical Oncology (ASCO) (2012)
- Presentation, complications and impact of concurrent Malaria Infection on Anticancer Therapy, Indian Journal of Cancer (July-Sep 2013)
- Book Chapters
- Thrombosis and Cancer
- Transplant in Hodgkin’s Lymphoma
- Diagnosis - Post-Transplant Lymphoproliferative Disorders
- Systemic Therapy of Breast Cancer
- Hormones and Breast Cancer
- Editor-in-Chief, Section – Recent Publications, Lung Cancer Consortium Asia
.png)
.png)